Biotechnology Value Fund's Ownership in Cidara Therapeutics

The filing discloses the ownership details of Biotechnology Value Fund, L.P. and its related entities in Cidara Therapeutics, Inc. as of September 30, 2025. The entities collectively own approximately 5.2% of the outstanding shares of Cidara Therapeutics. The filing includes detailed information on the number of shares owned by each entity, the percentage of ownership, and the nature of their ownership. The entities involved include Biotechnology Value Fund, L.P., BVF I GP LLC, Biotechnology Value Fund II, L.P., BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP Holdings LLC, BVF Partners L.P., BVF Inc., and Mark N. Lampert. The filing also includes certifications that the securities were not acquired for the purpose of influencing the control of the issuer.